Effect of COVID-19 on platelet count and its indices

Ertuğrul Güçlü1, Havva Kocayiğit2, Hüseyin Doğuş Okan1

  • 1. Sakarya University Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Sakarya, Turkey.

Revista Da Associacao Medica Brasileira (1992)
|September 16, 2020
PubMed

Insights

Low oxygen saturation and increased Mean Platelet Volume (MPV) in COVID-19 patients are significant predictors of mortality. Monitoring MPV may aid in assessing COVID-19 severity and patient outcomes.

Area of Science:

  • Hematology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Accessible laboratory tests are crucial for assessing COVID-19 severity.
  • Platelet parameters like count, Mean Platelet Volume (MPV), and distribution width are widely available.
  • Investigating their relationship with COVID-19 mortality is important for clinical practice.

Purpose of the Study:

  • To explore the association between COVID-19 mortality and platelet count, MPV, and platelet distribution width.
  • To identify potential laboratory markers for predicting mortality in COVID-19 patients.

Main Methods:

  • Retrospective analysis of 215 COVID-19 patients.
  • Patients categorized into moderate (oxygen saturation ≥90%) and severe (oxygen saturation <90%) groups.
  • Statistical analysis using SPSS, with p<0.05 considered significant.

Main Results:

  • Oxygen saturation at admission and MPV changes during hospitalization significantly predicted mortality.
  • Patients with oxygen saturation <90% had 8.4 times higher mortality.
  • A 1-unit increase in MPV correlated with a 1.76 times increased mortality risk.

Conclusions:

  • Mean Platelet Volume (MPV) can serve as an auxiliary marker for predicting COVID-19 mortality.
  • MPV, alongside lung capacity assessments, can enhance prognostic evaluations in COVID-19 patients.
Abstract

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
913